← Back to Clinical Trials
Recruiting NCT07891845

NCT07891845 Comparison of Two Surgical Techniques for Indirect Inguinal Hernia Repair

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07891845
Status Recruiting
Phase —
Sponsor Hitit University
Condition Indirect Inguinal Hernia
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2026-07-01
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Standard TAPP Repair With Complete Hernia Sac DissectionTAPP Repair With Primary Abandon of the Sac

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2026-07-01 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will compare two ways of managing the hernia sac during laparoscopic surgery for an indirect inguinal hernia, a type of groin hernia. A hernia sac is a pouch of tissue that extends through the hernia opening. In the standard technique, the sac is fully separated from nearby structures and returned to the abdomen. In the alternative technique, called Primary Abandon of the Sac (PAS), the lower part of the sac is left in place to reduce the amount of tissue dissection. Both techniques use mesh to repair the hernia. The main question is whether leaving the lower part of the sac in place results in an acceptably similar rate of seroma compared with the standard technique. A seroma is a collection of fluid near the area where surgery was performed. The study will also compare operation time, pain, quality of life, complications, return to daily activities, and whether the hernia comes back. The study plans to enroll 90 adults with a primary indirect inguinal hernia on one side who are scheduled for elective laparoscopic repair. Participants will be assigned by chance to one of the two surgical techniques, with an equal chance of receiving either technique. Participants and the researchers assessing their recovery will not know which technique was used; the operating surgeon will know. Participants will have follow-up assessments at 1 day, 7 days, 1 month, 6 months, and 12 months after surgery. The main assessment of seroma will take place 30 days after surgery.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older. * Primary unilateral indirect inguinal hernia. * Scheduled for elective laparoscopic inguinal hernia repair. * Suitable for general anesthesia and laparoscopic surgery. * Provision of written informed consent. Exclusion Criteria: * Bilateral inguinal hernia. * Recurrent inguinal hernia. * Direct inguinal or femoral hernia without a qualifying indirect inguinal hernia. * Incarcerated or strangulated hernia requiring emergency surgery. * Sliding hernia. * Large spermatic cord lipoma. * Previous preperitoneal surgery. * Contraindication to general anesthesia or laparoscopic surgery.

Contact & Investigator

Central Contact

Veysel Barış TURHAN, MD

✉ drbaristurhan@hotmail.com

📞 +905079945141

Frequently Asked Questions

Who can join the NCT07891845 clinical trial?

This trial is open to participants of all sexes, studying Indirect Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07891845 currently recruiting?

Yes, NCT07891845 is actively recruiting participants. Contact the research team at drbaristurhan@hotmail.com for enrollment information.

Where is the NCT07891845 trial being conducted?

This trial is being conducted at Çorum, Turkey (Türkiye).

Who is sponsoring the NCT07891845 clinical trial?

NCT07891845 is sponsored by Hitit University. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology